Marks Group Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.93M | Buy |
9,692
+305
| +3% | +$124K | 0.37% | 88 |
|
|
2025
Q1 | $4.67M | Buy |
9,387
+296
| +3% | +$147K | 0.45% | 80 |
|
|
2024
Q4 | $4.73M | Buy |
9,091
+271
| +3% | +$141K | 0.47% | 81 |
|
|
2024
Q3 | $5.46M | Sell |
8,820
-752
| -8% | -$465K | 0.52% | 79 |
|
|
2024
Q2 | $5.29M | Buy |
9,572
+307
| +3% | +$170K | 0.56% | 74 |
|
|
2024
Q1 | $5.38M | Buy |
9,265
+408
| +5% | +$237K | 0.56% | 73 |
|
|
2023
Q4 | $4.7M | Buy |
8,857
+504
| +6% | +$268K | 0.54% | 77 |
|
|
2023
Q3 | $4.23M | Sell |
8,353
-101
| -1% | -$51.1K | 0.52% | 78 |
|
|
2023
Q2 | $4.41M | Sell |
8,454
-34
| -0.4% | -$17.7K | 0.52% | 80 |
|
|
2023
Q1 | $4.89M | Buy |
8,488
+160
| +2% | +$92.2K | 0.63% | 71 |
|
|
2022
Q4 | $4.59M | Buy |
8,328
+2,910
| +54% | +$1.6M | 0.63% | 71 |
|
|
2022
Q3 | $2.75M | Buy |
5,418
+23
| +0.4% | +$11.7K | 0.42% | 88 |
|
|
2022
Q2 | $2.93M | Buy |
5,395
+45
| +0.8% | +$24.4K | 0.42% | 82 |
|
|
2022
Q1 | $3.16M | Buy |
5,350
+268
| +5% | +$158K | 0.4% | 89 |
|
|
2021
Q4 | $3.38M | Buy |
5,082
+23
| +0.5% | +$15.3K | 0.41% | 91 |
|
|
2021
Q3 | $2.91M | Buy |
5,059
+1,003
| +25% | +$576K | 0.39% | 93 |
|
|
2021
Q2 | $2.16M | Buy |
4,056
+63
| +2% | +$33.5K | 0.3% | 111 |
|
|
2021
Q1 | $1.79M | Buy |
3,993
+149
| +4% | +$66.8K | 0.27% | 109 |
|
|
2020
Q4 | $1.79M | Buy |
3,844
+134
| +4% | +$62.4K | 0.28% | 113 |
|
|
2020
Q3 | $1.64M | Buy |
3,710
+123
| +3% | +$54.3K | 0.3% | 109 |
|
|
2020
Q2 | $1.3M | Buy |
3,587
+1,291
| +56% | +$467K | 0.26% | 116 |
|
|
2020
Q1 | $654K | Buy |
2,296
+51
| +2% | +$14.5K | 0.17% | 136 |
|
|
2019
Q4 | $729K | Buy |
+2,245
| New | +$729K | 0.14% | 150 |
|